Cargando…

Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021

Diabetes mellitus is a metabolic disease characterised by elevated levels of blood glucose and is a leading cause of disability and mortality. Uncontrolled type 2 diabetes leads to complications such as retinopathy, nephropathy and neuropathy. Improved treatment of hyperglycaemia is likely to delay...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Yasser K, Al-Nowaiser, Noura, Al Harbi, Turki J, Tourkmani, Ayla M, Moharram, Maha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083884/
https://www.ncbi.nlm.nih.gov/pubmed/37012002
http://dx.doi.org/10.1136/bmjoq-2022-002037
_version_ 1785021618608668672
author Alotaibi, Yasser K
Al-Nowaiser, Noura
Al Harbi, Turki J
Tourkmani, Ayla M
Moharram, Maha
author_facet Alotaibi, Yasser K
Al-Nowaiser, Noura
Al Harbi, Turki J
Tourkmani, Ayla M
Moharram, Maha
author_sort Alotaibi, Yasser K
collection PubMed
description Diabetes mellitus is a metabolic disease characterised by elevated levels of blood glucose and is a leading cause of disability and mortality. Uncontrolled type 2 diabetes leads to complications such as retinopathy, nephropathy and neuropathy. Improved treatment of hyperglycaemia is likely to delay the onset and progression of microvascular and neuropathic complications. This article describes the efforts of 18 governmental hospitals in the Kingdom of Saudi Arabia that enrolled in a collaborative improvement project to improve the poor glycaemic control (HbA1c >9% to be less than 15%) of patients with diabetes by the end of 2021 among all the chronic illness clinics in the enrolled military hospitals. Enrolled hospitals were required to implement an evidence-based change package that included the implementation of diabetes clinical practice guidelines with standardised assessment and care planning tools. Furthermore, care delivery was standardised using a standard clinic scope of service that focused on multidisciplinary care teams. Finally, hospitals were required to implement diabetes registries that were used by case managers for poorly controlled patients. The project timetable was from October 2018 to December 2021. Diabetes poor control (HbA1c >9%) showed improved mean difference of 12.7% (34.9% baseline, 22.2% after) with a p value of 0.01. Diabetes optimal testing significantly improved from 41% at the start of the project in the fourth quarter of 2018, reaching 78% by the end of the fourth quarter of 2021. Variation between hospitals showed a significant reduction in the first quarter of 2021. The collaborative multilevel approach of standardising the care based on the best available evidence through policies, guidelines and protocols, patient-focused care and integrated care plan by a multidisciplinary team was associated with noticeable improvement in all key performance indicators of the project.
format Online
Article
Text
id pubmed-10083884
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-100838842023-04-11 Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021 Alotaibi, Yasser K Al-Nowaiser, Noura Al Harbi, Turki J Tourkmani, Ayla M Moharram, Maha BMJ Open Qual Quality Improvement Report Diabetes mellitus is a metabolic disease characterised by elevated levels of blood glucose and is a leading cause of disability and mortality. Uncontrolled type 2 diabetes leads to complications such as retinopathy, nephropathy and neuropathy. Improved treatment of hyperglycaemia is likely to delay the onset and progression of microvascular and neuropathic complications. This article describes the efforts of 18 governmental hospitals in the Kingdom of Saudi Arabia that enrolled in a collaborative improvement project to improve the poor glycaemic control (HbA1c >9% to be less than 15%) of patients with diabetes by the end of 2021 among all the chronic illness clinics in the enrolled military hospitals. Enrolled hospitals were required to implement an evidence-based change package that included the implementation of diabetes clinical practice guidelines with standardised assessment and care planning tools. Furthermore, care delivery was standardised using a standard clinic scope of service that focused on multidisciplinary care teams. Finally, hospitals were required to implement diabetes registries that were used by case managers for poorly controlled patients. The project timetable was from October 2018 to December 2021. Diabetes poor control (HbA1c >9%) showed improved mean difference of 12.7% (34.9% baseline, 22.2% after) with a p value of 0.01. Diabetes optimal testing significantly improved from 41% at the start of the project in the fourth quarter of 2018, reaching 78% by the end of the fourth quarter of 2021. Variation between hospitals showed a significant reduction in the first quarter of 2021. The collaborative multilevel approach of standardising the care based on the best available evidence through policies, guidelines and protocols, patient-focused care and integrated care plan by a multidisciplinary team was associated with noticeable improvement in all key performance indicators of the project. BMJ Publishing Group 2023-04-03 /pmc/articles/PMC10083884/ /pubmed/37012002 http://dx.doi.org/10.1136/bmjoq-2022-002037 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Alotaibi, Yasser K
Al-Nowaiser, Noura
Al Harbi, Turki J
Tourkmani, Ayla M
Moharram, Maha
Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021
title Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021
title_full Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021
title_fullStr Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021
title_full_unstemmed Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021
title_short Improving type 2 diabetes mellitus management in Ministry of Defense Hospitals in the Kingdom of Saudi Arabia 2018–2021
title_sort improving type 2 diabetes mellitus management in ministry of defense hospitals in the kingdom of saudi arabia 2018–2021
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083884/
https://www.ncbi.nlm.nih.gov/pubmed/37012002
http://dx.doi.org/10.1136/bmjoq-2022-002037
work_keys_str_mv AT alotaibiyasserk improvingtype2diabetesmellitusmanagementinministryofdefensehospitalsinthekingdomofsaudiarabia20182021
AT alnowaisernoura improvingtype2diabetesmellitusmanagementinministryofdefensehospitalsinthekingdomofsaudiarabia20182021
AT alharbiturkij improvingtype2diabetesmellitusmanagementinministryofdefensehospitalsinthekingdomofsaudiarabia20182021
AT tourkmaniaylam improvingtype2diabetesmellitusmanagementinministryofdefensehospitalsinthekingdomofsaudiarabia20182021
AT moharrammaha improvingtype2diabetesmellitusmanagementinministryofdefensehospitalsinthekingdomofsaudiarabia20182021